维普期刊资源整合服务平台（V6.5）

188篇 您的检索式：作者名="Karlan"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecol Oncol2004，95，：	1
2	Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures显示文摘	Li A J Baldwin R L Karlan B Y	2003	Am J Obstet Gynecol2003，189，1：	1
3	A phase Ⅰ/Ⅱ trial of rad/p53 (SCH 58500) gene replacement in recurrent ovarian caneer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
4	Defining cancer risks for BRCA germline mutations carriers implications for surgical prophylaxis 显示文摘	Karlan BY	2004	Gynecol Oncol2004，92，：	1
5	Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women显示文摘	Karlan BY Thorpe J Watabayashi K	2014	Cancer Epidemiol Biomarkers Prey2014，23，7：	1
6	Periostin promotes ovarian cancer angiogenesis and metastasis显示文摘	Min Zhu Marlena S. Fejzo Lee Anderson Judy Dering Charles Ginther Lillian Ramos Judith C. Gasson Beth Y. Karlan Dennis J. Slamon	2010	Gynecologic Oncology2010，，2：	1
7	A phase Ⅰ /Ⅱ trial of rAd/p53 (SCH 58500) gene replaeement in recurrent ovarian cancer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
8	Does Price Matter in Charitable Giving? Evidence from a Large - Scale Natural Field Experiment 显示文摘	Karlan Dean List John A	2007	The American Economic Review2007，97，5：	1
9	Ovarian cancer:the duplicity of CA125 measurement显示文摘	Karam A K Karlan B Y	2010	Nat Rev Clin Oncol2010，7，6：	1
10	Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer显示文摘	Konstantinopoulos PA Spentzos D Karlan BY	2010	J Clin Oncol2010，28，22：	1
11	Social Connections and Group Banking显示文摘	Karlan D		0，，2：	1
12	The prognostic significance of thrombocytosis in epithelial ovarian carcinoma显示文摘	Andrew J Li Alison C Madden Ilana Cass Ronald S Leuchter Leo D Lagasse Beth Y Karlan	2003	Gynecologic Oncology2003，，1：	1
13	Increased use of MRI for breast cancer surveillance and staging is not as- sociated with increased rate of mastectomy 显示文摘	Dang CM Zaghiyan K Karlan SR	2009	Am Surg2009，75，10：	1
14	A phase Ⅰ/ Ⅱ trial of rAd-p53 (SCH 58500) gene replacement in recurrent ovarian cancer显示文摘	Buller RE Runnebaum IB Karlan BY	2002	Cancer Gene Ther2002，9，7：	1
15	A phese Ⅰ /Ⅱ trial of rAd-P53 gene replacement in recurrent ovarian cancer显示文摘	Buller RE runnebanm IB Karlan BY	2002	Cancer Gnen Ther2002，9，7：	1
16	Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carci- noma 显示文摘	McIntosh MW Drescher C Karlan B	2004	Gynecologic Oncology2004，95，1：	1
17	Ovarian cancer: the duplicity of CA125 measurement 显示文摘	Karam A K Karlan B Y	2010	Nat Rev Clin Oneol2010，7，6：	1
18	Ovarian carcinoma cell cultures are resistant to TGF- beta1- mediated growth inhibition despite expression of functional receptors 显示文摘	Yamada SD Baldwin RL Karlan BY	1999	Gynecol Oncol1999，75，1：	1
19	Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer:Evidence supporting a mesothelial-toepithelial transition显示文摘	Bendoraite A Knouf E C Garg K S Parkin R K Kroh E M O'Briant K C Ventura A P Godwin A K Karlan B Y Drescher C W and others		0，，01：	1
20	Branchiogenic cysts:congenital or acquired显示文摘	Karlan MS Michel S Snyder WH	1965	Am J of Surg1965，110，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示